Targeted cancer therapy: interactions with other medicines

Potential clinical relevant drug–drug interactions: comparison between different compendia, do we have a validated method?

(2015) D. Conde-Estévez et al.   ANNALS OF ONCOLOGY

Reply to the letter to the editor 'Potential clinical relevant drug-drug interactions: comparison between different compendia, do we have a validated method?' by Conde-Estevez et al.

(2015) R. W. F. van Leeuwen et al.   ANNALS OF ONCOLOGY

Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions

(2015) R. W. F. van Leeuwen et al.   ANNALS OF ONCOLOGY

Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals

(2015) Heidemarie Kletzl et al.   ANTI-CANCER DRUGS

Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support

(2015) Richard T. Scheife et al.   DRUG SAFETY

Determining the optimal dose in the development of anticancer agents

(2014) Ron H. J. Mathijssen et al.   Nature Reviews Clinical Oncology

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

(2013) R W F van Leeuwen et al.   BRITISH JOURNAL OF CANCER

Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer

(2013) Masahide Fukudo et al.   CLINICAL PHARMACOKINETICS

Interactions between oral antineoplastic agents and concomitant medication: a systematic review

(2013) Esther Carcelero et al.   Expert Opinion On Drug Safety

An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib

(2013) J.F. Hilton et al.   LUNG CANCER

Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review

(2012) H.-H. Tsai et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Erlotinib and pantoprazole: a relevant interaction or not?

(2010) Rob Ter Heine et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Clinically Significant Drug–Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug Compendia

(2008) Chen-May Wong et al.   ANNALS OF PHARMACOTHERAPY

New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

(2008) Shiew-Mei Huang et al.   JOURNAL OF CLINICAL PHARMACOLOGY